ArticleBiology direct2024

SUMO3 inhibition by butyric acid suppresses cell viability and glycolysis and promotes gemcitabine antitumor activity in pancreatic cancer.

Liming Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.